SK Life Science Publishes Updated Real-World Experience on Cenobamate in Epilepsia Based on Recent 100,000 Patient Exposure Milestone

/PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous...

Related Keywords

Switzerland ,Canada ,China ,Israel ,United Kingdom ,Australia ,United States ,America ,Dexcel Pharma ,Angelini Pharma ,Louis Ferrari ,Williame Rosenfeld ,Marc Kamin ,Sk Life Science Inc ,European Union ,Sk Biopharmaceuticals Co Ltd ,Sk Life Science Lab ,Drug Administration ,Sk Inc ,Sk Group ,Endo International ,Source Sk Life Science Inc ,Epilepsy Foundation ,Paladin Labs Inc ,Ferrari ,Vice President ,Medical Affairs ,Greater China ,Latin America ,Middle East ,North Africa ,Ono Pharmaceutical ,Ignis Therapeutics ,Familial Short ,North American Antiepileptic Drug ,Science Labs ,Science Lab ,